Skip to main content
OpenTrials
Completed

NCT Number: NCT03601741

Use of Disposable Stethoscope Covers for Reduction of Stethoscope MRSA Contamination

This is a prospective pilot study using a randomized, controlled, single blinded, crossover trial design, evaluating the effect of daily antimicrobial stethoscope diaphragm covers versus uncovered stethoscope. Stethoscopes will be cleaned Sani-cloth germicidal disposable wipes which are effective against MRSA. Each participant will then be randomly assigned to 7 days in either the intervention or the control arm. At the end of the 7 days participants stethoscopes will be cleaned again. This will be followed by another 7 days in the arm that they are not in during the first 7 days.

The primary endpoint is MRSA colony count from stethoscope diaphragms cultures at 7 days, focusing on the difference between the intervention and the control periods. The secondary endpoint is the rate of hospital acquired MRSA infection in patients treated by residents during each period.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

New York University School of Medicine

New York, 10016, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Internal Medicine Residents

Exclusion criteria

  • NA

Treatment and study plan

Daily Antimicrobial Stethoscope Diaphragm Cover

Other

Patients will receive package with instructions to use stethoscope cover, and are then instructed to switch in 7 days

Uncovered Stethoscopes

Other

Patients receive instruction to begin with no covers, and are then instructed to switch in 7 days

Primary outcomes

  1. MRSA colony count cultured from stethoscope diaphragms

    Time frame: 7 Days

    Total CFU of each selected pathogen at 7 days compared by paired Mann-Whitney U tests, with each patient serving as their own control

Secondary outcomes

  1. Rate of hospital acquired MRSA infection in patients treated by participating residents

    Time frame: 14 Days

    Rates on nosocomial infection in each arm compared through use of Kaplan Meier curves

Sponsors and collaborators

Lead sponsor

NYU Langone Health

Other

Registry information

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Jul 26, 2018
Registry last updated
Sep 13, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.